Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morrison, C. First PI3k inhibitor launches into crowded hematology markets. Nat Biotechnol 32, 963–964 (2014). https://doi.org/10.1038/nbt1014-963
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1014-963
- Springer Nature America, Inc.
This article is cited by
-
Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors
Cancer Chemotherapy and Pharmacology (2019)